Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.
Journal: Journal of Crohn's & colitis
Published: May 26, 2021
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: June 04, 2019
Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
Journal: Gastroenterology
Published: September 12, 2018
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
Journal: Alimentary pharmacology & therapeutics
Published: February 14, 2018
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: December 13, 2017
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
Journal: Gastroenterology
Published: November 01, 2017
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Journal: The New England journal of medicine
Published: December 14, 2016
Soluble Factors Released by Endogenous Viable Cells Enhance the Antioxidant and Chemoattractive Activities of Cryopreserved Amniotic Membrane.
Journal: Advances in wound care
Published: January 26, 2015
Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion.
Journal: Advances in wound care
Published: January 26, 2015
A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds.
Journal: Ostomy/wound management
Published: December 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026